OverviewChartNewsTraderScreen

DZ Bank Call 5.6976 MDG2 20.12.20.../  DE000DW83PB5  /

Frankfurt Zert./DZB
11/10/2024  15:35:21 Chg.0.000 Bid11/10/2024 Ask- Underlying Strike price Expiration date Option type
0.001EUR 0.00% 0.001
Bid Size: 10,000		 -
Ask Size: -		 MEDIGENE AG NA O.N. 5.6976 EUR 20/12/2024 Call
GlobeNewswire 29/08 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
GlobeNewswire 28/08 Medigene to Present at Upcoming Investor Conferences
GlobeNewswire 26/08 Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effecti...
GlobeNewswire 14/08 Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08/08 Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
GlobeNewswire 08/08 Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell ...
GlobeNewswire 23/07 Medigene to Present at ESMO Congress 2024
GlobeNewswire 03/07 Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell ...
GlobeNewswire 27/06 Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
GlobeNewswire 24/06 Medigene Reports Results of Annual General Meeting
GlobeNewswire 21/06 Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
GlobeNewswire 20/06 Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumor...
GlobeNewswire 11/06 Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer
GlobeNewswire 28/05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 15/05 Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
GlobeNewswire 14/05 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
GlobeNewswire 07/05 Medigene to Present at Upcoming Conferences
GlobeNewswire 06/05 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 02/05 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell R...
GlobeNewswire 02/05 Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GlobeNewswire 26/04 Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire 25/04 Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GlobeNewswire 17/04 Medigene to Present at Upcoming Scientific Conferences
GlobeNewswire 08/04 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...